Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation

被引：13

作者：

Ogino, S

Wilson, RB

Grody, WW

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[3] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[4] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA

[5] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA

[6] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA

来源：

JOURNAL OF MEDICAL GENETICS | 2004年 / 41卷 / 05期

关键词：

D O I：

10.1136/jmg.2003.015065

中图分类号：

Q3 [遗传学];

学科分类号：

071007 [遗传学]; 090102 [作物遗传育种];

摘要：

[No abstract available]

引用

页数：9

共 23 条

[1]

The clinical significance of fetal echogenic bowel [J].

Al-Kouatly, HB ;

Chasen, ST ;

Streltzoff, J ;

Chervenak, FA .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (05) :1035-1038

[2]

Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].

Bobadilla, JL ;

Macek, M ;

Fine, JP ;

Farrell, PM .

HUMAN MUTATION, 2002, 19 (06) :575-606

[3]

BOUE A, 1986, HUM GENET, V74, P288

[4]

Bridge PJ, 1997, CALCULATION GENETIC

[5]

DICKE JM, 1992, OBSTET GYNECOL, V80, P778

[6]

Ferriman EL, 1999, PRENATAL DIAG, V19, P1177, DOI 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD713>3.0.CO

[7]

2-Q

[8]

Cystic fibrosis population carrier screening: Here at last-Are we ready? [J].

Grody, WW ;

Desnick, RJ .

GENETICS IN MEDICINE, 2001, 3 (02) :87-90

[9]

Hodge SE, 1999, AM J MED GENET, V82, P329, DOI 10.1002/(SICI)1096-8628(19990212)82:4<329::AID-AJMG10>3.0.CO

[10]

2-D

← 1 2 3 →